Navigation Links
ISS/Risk Metrics Group and Glass Lewis Recommend VaxGen Stockholders Vote 'For' Proposed Merger With OXiGENE
Date:1/25/2010

SOUTH SAN FRANCISCO, Calif., Jan. 25 /PRNewswire-FirstCall/ -- VaxGen, Inc. (OTC Bulletin Board: VXGN), announced today that Institutional Shareholder Services/Risk Metrics Group (ISS) and Glass, Lewis & Co. (Glass Lewis), two leading independent proxy advisory firms, recommend that VaxGen stockholders vote "FOR" the proposed merger of VaxGen, Inc. and OXiGENE, Inc. and "FOR" the Proposal to adjourn the VaxGen special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the first proposal.

(Logo:  http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO)

"We are pleased that both ISS and Glass Lewis, having thoroughly evaluated the proposed merger, agree with the VaxGen and OXiGENE boards of directors in recommending that stockholders vote in favor of these proposals," said James Panek, VaxGen President.  "We believe the merger with OXiGENE, which was carefully considered and unanimously approved by the VaxGen board of directors, provides the best alternative for our stockholders."

Both ISS and Glass Lewis recommend that VaxGen stockholders vote to approve both proposals:

  • A vote FOR Proposal 1: To adopt the Agreement and Plan of Merger dated as of October 14, 2009 by and among OXiGENE, Inc., VaxGen. Inc., OXiGENE Merger Sub, Inc. and James Panek as the VaxGen stockholder representative, and the transactions contemplated thereby, including the merger;
  • A vote FOR Proposal 2: To adjourn the VaxGen special meeting, if necessary, to solicit additional proxies if there are not su
    '/>"/>

SOURCE VaxGen, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. RiskMetrics Recommends Taro Shareholders Vote Against Taro Board of Directors
2. Accumetrics Closes 2009 with Positive Outlook
3. Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference
4. Accumetrics Announces $16.5M in New Capital Financing
5. Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
6. CRi Oosight(TM) Instrument Crucial in IVF Breakthrough Demonstrating a Correlation Between Non-Invasive Egg Metrics and Pregnancy
7. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
8. Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial
9. Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial
10. Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
11. AMP Supports the Creation of a National Immunization Technical Advisory Group in Cote dIvoire
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 25, 2014 Reinforcing its commitment ... (NYSE: PHG AEX: PHIA) today ... Administration (FDA) for its IQon Spectral CT , ... first-of-its kind technology adds a new dimension to Computed ... ability to characterize structures based on their material content ...
(Date:11/26/2014)... 2014   Heska Corporation (NASDAQ: HSKA ... provider of advanced veterinary diagnostic and other specialty veterinary ... Chair, will attend The Benchmark Company, LLC,s Micro Cap Discovery ... be held at The Palmer House Hilton, 17 E. Monroe ... to 2:30 p.m. Please email hska@haydenir.com or contact ...
(Date:11/26/2014)... 2014  Breckenridge Pharmaceutical, Inc. announced today that ... with Pii (Pharmaceutics International, Inc.) ( Hunt ... Pii expect to develop and commercialize several new ... will develop, manufacture and supply the products, and ... its own label.  The drugs, comprised of four ...
Breaking Medicine Technology:Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3Heska to Attend Benchmark Micro Cap Discovery Conference 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2
... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) today announced that the following presentations,will ... formerly XYOTAX(TM)),at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting,May 30 through ... Poster # ... (Abstract#) Sat., ...
... First and Only Treatment for Hunter Syndrome Now Approved in ... ... Worldwide, BASINGSTOKE, England and CAMBRIDGE, Massachusetts, May ... company, announced that ELAPRASE(R),(idursulfase), a human enzyme replacement therapy for ...
Cached Medicine Technology:Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 2Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 2Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 4Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 5
(Date:11/26/2014)... November 26, 2014 ISI Telemanagement ... solutions, has been award the 2014 Lync ... This award comes as a great honor to ... the Lync ecosystem. Specifically, ISI offers an integrated ... of Lync communication, including voice, video, Lync IM, ...
(Date:11/26/2014)... 26, 2014 Bunion Bootie, the newest ... in an early celebration of the early holiday shopping ... offered at the promotional price of $29.95 each (normally ... addition to any automatic discounts applied when buying more ... website for complete details. It’s simple: purchasing more ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Sonoran ... ANP-BC, recently received the Distinguished Preceptorship Award from ... for her role in the advancement of nurse ... of an individual who had made a significant ... NPs. The American Association of Nurse Practitioners (AANP) ...
(Date:11/26/2014)... Teens prescribed anti-anxiety or sleep medications are much ... teens, a new study warns. The findings ... on teenagers before prescribing these drugs to them, ... realize the abuse potential," said lead researcher Carol ... School of Nursing. "These drugs produce highly attractive ...
(Date:11/26/2014)... Randy Dotinga HealthDay Reporter ... such as Prilosec and Nexium may disrupt the makeup of ... infections and other problems, a small new study suggests. ... more likely users will become ill, and study authors aren,t ... However, these antacids "should be used at the lowest ...
Breaking Medicine News(10 mins):Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 3
... HealthDay Reporter , MONDAY, April 30 (HealthDay News) -- ... disease, but most don,t know it and for most it ... has been debate about whether healthy people should be screened ... U.S. Preventive Services Task Force (USPSTF) says no. "The ...
... HealthDay Reporter , MONDAY, April 30 (HealthDay News) ... depending on where you,re treated in the United States, according ... that follow five simple strategies -- including good teamwork and ... survival rates of other medical centers, the study found. ...
... HealthDay Reporter , MONDAY, April 30 (HealthDay News) ... interferes with breast-feeding is wrong, a new small study ... born between June 2010 and August 2011, Oregon Health ... pacifiers -- also known as binkies, corks and soothers ...
... Like a police officer calling for backup while also keeping ... the brain take a two-tier approach to fighting off a ... finds. For the first time, the scientists managed to ... locked onto a model of virus-infected brain cells, while also ...
... competent than other physicians regarding knowledge of patient imaging ... The study conducted at Thomas Jefferson University in Philadelphia ... 2,685 non-radiology physicians. "On a scale of one ... patient safety was rated as 3.1 by radiologists and ...
... images from the "cloud" making it faster for them ... those physicians might be, according to a preliminary report ... academic institutions., The image share project includes the University ... Clinic in Rochester, MN, the University of Maryland in ...
Cached Medicine News:Health News:Routine Kidney Disease Screening Not Worthwhile, Experts Say 2Health News:Routine Kidney Disease Screening Not Worthwhile, Experts Say 3Health News:Heart Attack Survival Varies Widely Among Hospitals, Study Finds 2Health News:Heart Attack Survival Varies Widely Among Hospitals, Study Finds 3Health News:Pacifiers Don't Discourage Breast-Feeding, Study Says 2Health News:Pacifiers Don't Discourage Breast-Feeding, Study Says 3Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 2Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 3Health News:Image share project gives patients and physicians anytime, anywhere access to medical images 2
... Menicon Super EX is a rigid ... one of its specific characteristics as hard ... correction and show excellent performance against astigmatism. ... material is the combination of fluoromethacrylate, Siloxanylmethacrylate ...
Magniclear is the first presbyopic lens to combine the clear distance optics of a spherical lens, the intermediate visual performance of a multifocal and the predictably crisp, near power of a bifoca...
Boston Multivision design is manufactured in Boston ES material for early presbyope patients. Boston Multivision lens provides crisp, clear vision at near, intermediate, and far distances and excelle...
... to stain intraocular membranes in vitreoretinal surgery, ... injecting Membraneblue in an air-filled vitreous cavity, ... the dye. After removal of all excess ... can easily be distinguished from the underlying, ...
Medicine Products: